SEC v. Lemelson, et al
| US SECURITIES & EXCHANGE COMMISSION |
| GREGORY M. LEMELSON, a/k/a Father Emmanuel Lemelson, LEMELSON CAPITAL MANAGEMENT, LLC and THE AMVONA FUND, LP |
| LIGAND PHARMACEUTICALS, INC. and VIKING THERAPEUTICS, INC. |
| 24-1754 |
| August 20, 2024 |
| U.S. Court of Appeals, First Circuit |
| Securities/Commodities/Exchange |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 18, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
ORDER granting motion to extend time to file brief and appendix filed by Appellants Gregory M. Lemelson and Lemelson Capital Management, LLC. Brief and Appendix due 11/27/2024 for appellants Gregory M. Lemelson and Lemelson Capital Management, LLC. [24-1754] (JW) [Entered: 10/18/2024 05:09 PM]
|
| MOTION to extend time to file brief and appendix filed by Appellants Lemelson Capital Management, LLC and Gregory M. Lemelson. Served on 10/16/2024. [24-1754] (DSB) [Entered: 10/16/2024 03:20 PM] |
| NOTICE issued. The following attorneys have failed to register for an appellate ECF account and will no longer receive notice of court issued documents in this case: Virginia M. Rosado Desilets for SEC, Sonia G. Torrico for SEC, Andrea Abarca for Ligand Pharmaceuticals, Inc. and Sean P. Tonolli for Ligand Pharmaceuticals, Inc. [24-1754] (JW) [Entered: 10/07/2024 04:55 PM] |
|
ORDER entered: Appellee Securities and Exchange Commission's assented to motion to extend time to file its brief is premature as the appellant's brief has not been accepted for filing. [24-1754] (JW) [Entered: 10/07/2024 05:03 PM]
|
| ASSENTED TO MOTION to extend time to file brief filed by Appellee SEC. Served on 10/03/2024. [24-1754] (TNM) [Entered: 10/03/2024 12:53 PM] |
| NOTICE of appearance on behalf of Appellee SEC filed by Attorney Melinda Hardy. Served on 10/03/2024. [24-1754] (MH) [Entered: 10/03/2024 11:28 AM] |
| BRIEFING schedule set. Brief and Appendix due 10/28/2024 for appellants Gregory M. Lemelson and Lemelson Capital Management, LLC. Pursuant to F.R.A.P. 31(a), appellee's brief will be due 30 days following service of appellant's brief and appellant's reply brief will be due 21 days following service of appellee's brief. [24-1754] (JW) [Entered: 09/18/2024 05:35 PM] |
| NOTICE issued. After 09/25/2024, the following attorneys will no longer receive notice of court issued documents in this case unless they register for an appellate ECF account: Virgnia M. Rosado Desilets for SEC, Sonia G. Torrico for SEC, Andrea Abarca for Ligand Pharmaceuticals, Inc. and Sean P. Tonolli for Ligand Pharmaceuticals, Inc. [24-1754] (JW) [Entered: 09/11/2024 09:11 AM] |
| NOTICE of appearance on behalf of Appellee SEC filed by Attorney Timothy N. McGarey. Served on 08/26/2024. [24-1754] (TNM) [Entered: 08/26/2024 11:33 AM] |
| DOCKETING statement filed by Appellants Lemelson Capital Management, LLC and Gregory M. Lemelson. Served on 08/26/2024. [24-1754] (DSB) [Entered: 08/26/2024 12:30 PM] |
| TRANSCRIPT report/order form filed by Appellants Lemelson Capital Management, LLC and Gregory M. Lemelson indicating transcripts are not necessary for this appeal. Served on 08/26/2024. [24-1754] (DSB) [Entered: 08/26/2024 12:32 PM] |
| NOTICE of appearance on behalf of Appellants Lemelson Capital Management, LLC and Gregory M. Lemelson filed by Attorney Douglas S. Brooks. Served on 08/26/2024. [24-1754] (DSB) [Entered: 08/26/2024 12:31 PM] |
| CIVIL CASE docketed. Notice of appeal (doc. #318) filed by Appellants Gregory M. Lemelson and Lemelson Capital Management, LLC. Appearance form, Docketing Statement, and Transcript Report/Order form due 09/03/2024. [24-1754] (JW) [Entered: 08/20/2024 10:33 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
